E.e.s Granule, For Suspension
Product Images NDC 24338-136

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for E.e.s (NDC 24338-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ees 01)

Chemical structure of erythromycin ethylsuccinate, the active ingredient in the product E.E.S. The diagram shows the molecular arrangement of atoms and functional groups typical of this macrolide antibiotic derivative.*

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Label for E.E.S. 400 film-coated tablets containing erythromycin ethylsuccinate equivalent to 400 mg erythromycin activity. The package contains 30 tablets by Arbor Pharmaceuticals, LLC. Instructions advise not accepting if the seal over the bottle is broken or missing and to dispense in a light-resistant container. The label includes dosing information and warnings, along with a barcode and serialization space.*

FDA Label Image

Principal Display Panel (100 mL Bottle Label)

Label for E.E.S. Granules containing erythromycin ethylsuccinate for oral suspension, USP. The product provides erythromycin activity at 200 mg per 5 mL when reconstituted. The label includes NDC 24338-134-02 and indicates a 100 mL quantity when mixed. Directions for mixing, storage, and administration guidelines are also shown. The labeler is Arbor Pharmaceuticals, Inc., now Azurity Pharmaceuticals, Inc.*

FDA Label Image

Principal Display Panel (5 mL Bottle Label)

Label for E.E.S. Granules, erythromycin ethylsuccinate for oral suspension, USP, 200 mg per 5 mL when reconstituted. The label includes NDC 24338-136-10 and directs that the 200 mL suspension is for oral use. Manufacturer is Arbor Pharmaceuticals, Inc., now Azurity Pharmaceuticals, Inc. The label also contains preparation directions, dosage information, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.